{
    "Trade/Device Name(s)": [
        "eBsensor Blood Glucose Monitoring System",
        "eB-G"
    ],
    "Submitter Information": "VISGENEER, INC.",
    "510(k) Number": "K062555",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043197"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "December 12, 2006",
    "Summary Letter Received Date": "December 15, 2006",
    "Submission Date": "August 25, 2006",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for VISGENEER eBsensor Blood Glucose Monitoring System using electrochemical biosensor technology for blood glucose measurement",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood; for home (OTC) use by people with diabetes or in clinical settings by healthcare professionals to monitor effectiveness of diabetes control",
    "fda_folder": "Clinical Chemistry"
}